Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis.
Saved in:
| Title: | Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis. |
|---|---|
| Authors: | Ferreira C; Department of Dermatology, Centro Académico Clínico ICBAS/Santo António, Rua Dão Manuel II 101, 4050-342, Porto, Portugal., Torres T; Department of Dermatology, Centro Académico Clínico ICBAS/Santo António, Rua Dão Manuel II 101, 4050-342, Porto, Portugal. torres.tiago@outlook.com.; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, 4050-342, Porto, Portugal. torres.tiago@outlook.com. |
| Source: | American journal of clinical dermatology [Am J Clin Dermatol] 2026 May; Vol. 27 (3), pp. 479-492. Date of Electronic Publication: 2026 Mar 12. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!